✦ LIBER ✦

Low efficacy partial agonists of the α4β2 nicotinic acetylcholine receptor (nAChR). Does functional efficacy govern in vivo response?

✍ Scribed by Jotham W. Coe; Paige R. Brooks; Michael C. Wirtz; Michael G. Vetelino; Eric P. Arnold; Steven B. Sands; Thomas I. Davis; Lorraine A. Lebel; Carol B. Fox; Alka Shrikhande; Robert S. Mansbach; Leslie K. Chambers; Charles C. Rovetti; David W. Schulz; F. David Tingley III; Brian T. O’Neill; Hans Rollema

Book ID: 113488929
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 56 KB
Volume: 78
Category: Article
ISSN: 0006-2952
DOI: 10.1016/j.bcp.2009.06.078

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pre-clinical properties of the α4β2 nico

Pre-clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence

✍ H Rollema; A Shrikhande; KM Ward; FD Tingley III; JW Coe; BT O'Neill; E Tseng; E 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 460 KB

Preclinical properties of the α4β2 nAChR

Preclinical properties of the α4β2 nAChR partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence

✍ H. Rollema; A. Shrikhande; K.M. Ward; J.W. Coe; E. Tseng; E.Q. Wang; M. De Vries 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

P2-3 THE EFFICACY AND TOLERABILITY OF VA

P2-3 THE EFFICACY AND TOLERABILITY OF VARENICLINE, AN α4β2 NICOTINIC ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, FOR SMOKING CESSATION IN TAIWANESE AND KOREAN SMOKERS

✍ Dae-Hyun Kim; Shih-Tzu Tsai; Hong-Jun Cho; Wen-Dau Chang; Cheol-Hwan Kim; Huey-S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 136 KB

The α4β2 nicotinic acetylcholine-recepto

The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats

✍ Eoin C. O’Connor; Dale Parker; Hans Rollema; Andy N. Mead 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 416 KB

Efficacy and safety of the α4β2 neuronal

Efficacy and safety of the α4β2 neuronal nicotinic receptor agonist ABT-894 in patients with diabetic peripheral neuropathic pain

✍ Michael C. Rowbotham; Armen Arslanian; Wolfram Nothaft; W. Rachel Duan; Andrea E 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 250 KB

Efficacy and tolerability of varenicline

Efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers

✍ Masakazu Nakamura; Akira Oshima; Yoko Fujimoto; Nami Maruyama; Taro Ishibashi; K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 244 KB